Advertisement

Therapeutic Approaches to Bone Cancer Pain

  • M. Baciuchka-Palmaro
  • J. L. Mouysset
  • D. Spiegel

Abstract

Pain is one of the major symptoms of bone cancer. In 1984, 19 million cancer patients around the world suffered pain (Elliot and Foley, 1989). The prevalence of cancer pain is an important problem, as 30% of patients receiving curative treatment and 70% of patients with palliative care suffer pain because of the progression of the tumour (Greenwald et al, 1987).

Keywords

Palliative Care Bone Metastasis Cancer Pain Bone Cancer Oral Morphine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beecher HK (1956) Relationship of significance of wound to pain experienced. JAMA 161: 1609–1613.CrossRefGoogle Scholar
  2. Berenson JR, Lichenstein A, Porter L et al (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. N Engl J Med 334: 488–493.PubMedCrossRefGoogle Scholar
  3. Bonica JJ, Loeser JD (1990) Medical evaluation of the patient with pain. In: Bonica JJ, Loeser JD, Chapman CR et al (eds) The management of pain, 2nd edn. Lea Febiger, Pennsylvania, pp 563–580.Google Scholar
  4. Clain A (1965) Secondary malignant disease of bone. Br J Cancer 19: 5.CrossRefGoogle Scholar
  5. De Conno F, Caraceni A (1996) Manual of cancer pain. pp 19.CrossRefGoogle Scholar
  6. De Conno F, Ripamonti C, Sbanotto A et al (1993) A clinical note on sublingual buprenorphine. J Palliative Care 9: 44–46.Google Scholar
  7. Durandeau A, Genste R (1989) Traitement chirurgical des fractures métastatiques et des métastases des os longs. A propos de 73 cas. Revue de Chirurgie Orthopédique et Réparatrice de l’Appareil Locomoteur 75: 1–10.Google Scholar
  8. Elliot K, Foley KM (1989) Neurologic pain syndromes in patients with cancer. Neurol Clin 7: 333–360.Google Scholar
  9. Erickson MH (1959) Hypnosis in painful terminal illness. Am J Clin Hypn 1: 117–121.CrossRefGoogle Scholar
  10. Fidler M (1981) Incidence of fractures through metastases in long bones. Acta Orthop Scand 52: 623–627.PubMedCrossRefGoogle Scholar
  11. Fine PG, Marcus M, DeBoer AJ et al (1991) An open label study of oral transmucosal fentanyl citrate ( OTFC) for the treatment of breakthrough cancer pain. Pain 45: 149–155.PubMedCrossRefGoogle Scholar
  12. Greenwald HP, Bonica JJ, Bergner M (1987) The prevalence of pain in four cancers. Cancer 60: 2563–2569.PubMedCrossRefGoogle Scholar
  13. Holland JC (1993) Principles of psychooncology. In: Holland JC, Frei E (eds) Cancer medicine, 3rd edn. Lea & Febiger, Philadelphia, pp 1017–1033.Google Scholar
  14. Holroyd J (1996) Hypnosis treatment of clinical pain: understanding why hypnosis is useful. Int J Clin Exp Hypn XLIV(1): 33–51.CrossRefGoogle Scholar
  15. Korte W, De Stoutz N, Morant R (1996) Day-to-day titration to initiate transdermal fentanyl in patients with cancer pain: short-and long-term experiences in a prospective study of 39 patients. J Pain Symptom Management 11: 139–146.CrossRefGoogle Scholar
  16. Krakowski I (1996) Chirurgie, radiotherapie et traitements médicaux spécifiques dans la prise en charge de la douleur cancéreuse. In: European School of Oncology (eds) Douleur et cancer, pp 51–68.Google Scholar
  17. Krakowski I, Falcoff H, Gestin Y et al (1995) Recommandations pour une bonne pratique dans la prise en charge de la douleur du cancer chez l’adulte et l’enfant. Opération «Standards, Options et Recommandations» en cancérologie de la Fédération Nationale des Centres de Lutte Contre Le Cancer. Bulletin du Cancer 82 (suppl 4): 244–315.Google Scholar
  18. Miser AW, Narang PK, Dothge JA et al (1989) Transdermal fentanyl for pain control in patients with cancer. Pain 37: 15–21.PubMedCrossRefGoogle Scholar
  19. Sacerdote P (1980) Hypnosis and terminal illness. In: Burroughs GD, Dennerstein L (eds) Handbook of hypnosis and psychosomatic medicine. Elsevier/North-Holland Biomedical Press, New York.Google Scholar
  20. Spiegel D (1981) Hypnosis in the treatment of psychosomatic symptoms and pain. Psychiatric Ann 11 (9): 24–30.Google Scholar
  21. Spiegel D, Bloom JR (1983a) Pain in metastatic breast cancer. Cancer 52: 341–345.PubMedCrossRefGoogle Scholar
  22. Spiegel D, Bloom JR (1983b) Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45: 333–339.PubMedGoogle Scholar
  23. Trijsburg RW, Van Knippenberg FCE, Rijpma SE (1992) Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 54: 489–517.PubMedGoogle Scholar
  24. Tubiana-Hulin M (1996) Traitements médicaux des métastases osseuses. Bulletin du Cancer/ Radiothérapie 83: 299–304.Google Scholar
  25. Turner JH, Claringbold PG, Hetherington EL (1989) A phase I study of samarium-153 ethylnediaminetetramethylene phosphonate therapy for disseminated skeletal metastases. J Clin Oncol 7: 1926–1931.PubMedGoogle Scholar
  26. Woodforde JM, Fielding JR (1970) Pain and cancer. J Psychosom Res 14: 365–370.PubMedCrossRefGoogle Scholar
  27. World Health Organization (1996) Cancer pain relief, 2nd edn. World Health Organization, Geneva.Google Scholar

Copyright information

© Springer-Verlag London 2002

Authors and Affiliations

  • M. Baciuchka-Palmaro
  • J. L. Mouysset
  • D. Spiegel

There are no affiliations available

Personalised recommendations